Patient-Derived Organoids Highlight Strain-Specific Potential of Engineered Bacteria in Colorectal Cancer
Researchers at the University of California San Diego and collaborating institutions utilized patient-derived organoids to evaluate how different engineered bacterial strains interact with colorectal cancer tissue.
Key points
- Patient-derived organoids help test engineered bacteria for cancer therapy.
- Attenuated Salmonella colonized tumor organoids more efficiently than E. coli Nissle.
- Tumor responses varied based on patient genotypes, highlighting interpatient differences.
A team of investigators has demonstrated that laboratory-grown miniature tumor models, or organoids, can effectively test how engineered bacteria target and colonize colorectal cancer tissues. Published in Nature Health Sciences, the study developed a co-culture platform pairing patient-derived colorectal cancer and matched normal mucosa organoids with two microbial strains: attenuated Salmonella typhimurium and Escherichia coli Nissle 1917. Because standard laboratory cell lines frequently fail to capture the complex architecture and genetic diversity of actual tumors, these three-dimensional organoids offer a physiologically relevant alternative for evaluating microbial cancer therapies.
The findings indicate that both bacterial strains preferentially colonize colorectal cancer organoids rather than matched healthy mucosal tissue. However, the study observed distinct differences between the microbes: attenuated Salmonella achieved substantially higher colonization efficiency and induced much stronger transcriptional and morphological changes in the host tumor cells compared to E. coli Nissle 1917. Additionally, cellular responses varied across genotypically distinct patient lines, pointing to potential interpatient variability in how tumors react to microbial treatments. Financial disclosures note that several authors hold equity or advisory roles in GenCirq Inc., a company focused on cancer therapeutics.
As an early-stage preclinical investigation utilizing laboratory organoid models, these findings remain far from clinical application. Observational and in vitro models provide valuable insights into chassis selection, but cannot guarantee safety or efficacy in human patients. Readers should consult qualified healthcare professionals regarding any personal medical decisions or ongoing clinical trials.
What to know: Patient-derived organoids may help researchers select more effective engineered bacterial strains for targeting solid tumors, though human clinical studies are still required to determine safety and real-world outcomes.
Source Nature Health Sciences — nature.com/articles/s43856-026-01992-x ↗
Read next
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…
🏃FitnessA Structured Approach to Beginning a Strength and Cardio Routine
A new four-week training program offers beginners a guided path to incorporating strength training and cardiovascular exercise into their daily lives.
🧠Mind & Mental HealthThe Role of Daily Mobility Training in Managing Sedentary Tension
A two-week personal trial suggests that incorporating short, daily mobility exercises may help alleviate stiffness associated with sedentary desk work. Experts note that …
🧠Mind & Mental HealthNew Theoretical Framework Explores Memory Formation and Dementia
Researchers have proposed a new model suggesting the brain's limbic system functions similarly to generative AI, potentially offering a new way to understand and classify…